Claudia A. Staab-Weijnitz

Author

Ludwig-Maximilians-Universität München ORCID

Also Known As

C A Staab-Weijnitz, C Staab-Weijnitz, C. A. Staab, C. Staab-Weijnitz, C.A. Staab-Weijnitz, Claudia A Staab, Claudia A Staab-Weijnitz, Claudia A. Staab, Claudia A. Staab-Weijnitz, Claudia Alma Staab

100

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Ludwig-Maximilians-Universität München German Center for Lung Research Helmholtz Zentrum München Asklepios Fachkliniken München-Gauting Karolinska Institutet

About

Claudia A. Staab-Weijnitz is an author at Ludwig-Maximilians-Universität München specializing in medicine, cell biology, and lung inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	406
2	Natural Sciences	3	3	93
3	Biochemistry	3	3	80
4	Engineering	2	2	200
5	Allergy	2	2	59

Claudia A. Staab-Weijnitz

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices Hani N. Alsafadi, Claudia A. Staab-Weijnitz, Mareike Lehmann, American Journal of Physiology-Lung Cellular and Molecular Physiology	2017	258
Cigarette smoke alters primary human bronchial epithelial cell differentiation at the air-liquid interface Andrea C. Schamberger, Claudia A. Staab-Weijnitz, Nikica Mise-Racek, Scientific Reports	2015	172
A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly Larissa Knüppel, Yoshihiro Ishikawa, Michaela Aichler, American Journal of Respiratory Cell and Molecular Biology Acute Lung InjuryCollagen FibrilsAntifibrotic TherapyEngineeringInflammatory Lung Disease	2017	167
Deep Proteome Profiling Reveals Common Prevalence of MZB1-Positive Plasma B Cells in Human Lung and Skin Fibrosis Herbert B. Schiller, Christoph H. Mayr, Gabriela Leuschner, American Journal of Respiratory and Critical Care Medicine	2017	116
S100a4 Is Secreted by Alternatively Activated Alveolar Macrophages and Promotes Activation of Lung Fibroblasts in Pulmonary Fibrosis Wei Zhang, Shinji Ohno, Beatrix Steer, Frontiers in Immunology	2018	100
FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis Claudia A. Staab-Weijnitz, Isis E. Fernandez, Larissa Knüppel, American Journal of Respiratory and Critical Care Medicine	2015	99
Reduction of <i>S</i>-nitrosoglutathione by alcohol dehydrogenase 3 is facilitated by substrate alcohols via direct cofactor recycling and leads to GSH-controlled formation of glutathione transferase inhibitors Claudia A. Staab-Weijnitz, Johan Ålander, Margareta Brandt, Biochemical Journal	2008	90
Quantitative proteomic profiling of extracellular matrix and site-specific collagen post-translational modifications in an in vitro model of lung fibrosis Juliane Merl‐Pham, Trayambak Basak, Larissa Knüppel, Matrix Biology Plus	2019	82
A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets Annika Kratzel, Jenna N. Kelly, Philip V’kovski, PLoS Biology	2021	64
The Janus face of alcohol dehydrogenase 3 Claudia A. Staab-Weijnitz, Johan Ålander, Ralf Morgenstern, Chemico-Biological Interactions Aldo-keto ReductaseAldehyde DehydrogenaseBiochemistryNatural SciencesJanus Face	2008	45

Page 1